Ko M[au] - Search Results

Year	Number of Results
1965	1
1966	1
1967	2
1968	3
1970	1
1972	1
1977	1
1978	1
1980	1
1982	3
1983	1
1984	1
1985	5
1987	4
1988	3
1989	3
1990	5
1991	6
1992	4
1993	5
1994	6
1995	7
1996	5
1997	10
1998	16
1999	18
2000	19
2001	26
2002	17
2003	22
2004	39
2005	51
2006	38
2007	42
2008	74
2009	61
2010	81
2011	88
2012	100
2013	101
2014	114
2015	99
2016	108
2017	77
2018	98
2019	120
2020	150
2021	149
2022	128

1

In vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes.

Jin X, Simmons SK, Guo A, Shetty AS, Ko M, Nguyen L, Jokhi V, Robinson E, Oyler P, Curry N, Deangeli G, Lodato S, Levin JZ, Regev A, Zhang F, Arlotta P. Jin X, et al. Among authors: ko m. Science. 2020 Nov 27;370(6520):eaaz6063. doi: 10.1126/science.aaz6063. Science. 2020. PMID: 33243861 Free PMC article.

2

STING controls nociception via type I interferon signalling in sensory neurons.

Donnelly CR, Jiang C, Andriessen AS, Wang K, Wang Z, Ding H, Zhao J, Luo X, Lee MS, Lei YL, Maixner W, Ko MC, Ji RR. Donnelly CR, et al. Among authors: ko mc. Nature. 2021 Mar;591(7849):275-280. doi: 10.1038/s41586-020-03151-1. Epub 2021 Jan 13. Nature. 2021. PMID: 33442058 Free PMC article.

3

TIGIT/CD226 Axis Regulates Anti-Tumor Immunity.

Yeo J, Ko M, Lee DH, Park Y, Jin HS. Yeo J, et al. Among authors: ko m. Pharmaceuticals (Basel). 2021 Feb 28;14(3):200. doi: 10.3390/ph14030200. Pharmaceuticals (Basel). 2021. PMID: 33670993 Free PMC article. Review.

4

CTLA-4 blockade drives loss of T_reg stability in glycolysis-low tumours.

Zappasodi R, Serganova I, Cohen IJ, Maeda M, Shindo M, Senbabaoglu Y, Watson MJ, Leftin A, Maniyar R, Verma S, Lubin M, Ko M, Mane MM, Zhong H, Liu C, Ghosh A, Abu-Akeel M, Ackerstaff E, Koutcher JA, Ho PC, Delgoffe GM, Blasberg R, Wolchok JD, Merghoub T. Zappasodi R, et al. Among authors: ko m. Nature. 2021 Mar;591(7851):652-658. doi: 10.1038/s41586-021-03326-4. Epub 2021 Feb 15. Nature. 2021. PMID: 33588426 Free PMC article.

5

IL-23/IL-17A/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice.

Luo X, Chen O, Wang Z, Bang S, Ji J, Lee SH, Huh Y, Furutani K, He Q, Tao X, Ko MC, Bortsov A, Donnelly CR, Chen Y, Nackley A, Berta T, Ji RR. Luo X, et al. Among authors: ko mc. Neuron. 2021 Sep 1;109(17):2691-2706.e5. doi: 10.1016/j.neuron.2021.06.015. Epub 2021 Jul 19. Neuron. 2021. PMID: 34473953 Free PMC article.

6

Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis.

Koh EH, Yoon JE, Ko MS, Leem J, Yun JY, Hong CH, Cho YK, Lee SE, Jang JE, Baek JY, Yoo HJ, Kim SJ, Sung CO, Lim JS, Jeong WI, Back SH, Baek IJ, Torres S, Solsona-Vilarrasa E, Conde de la Rosa L, Garcia-Ruiz C, Feldstein AE, Fernandez-Checa JC, Lee KU. Koh EH, et al. Among authors: ko ms. Gut. 2021 Oct;70(10):1954-1964. doi: 10.1136/gutjnl-2020-322509. Epub 2020 Nov 18. Gut. 2021. PMID: 33208407 Free PMC article.

7

Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice.

Ko MS, Yun JY, Baek IJ, Jang JE, Hwang JJ, Lee SE, Heo SH, Bader DA, Lee CH, Han J, Moon JS, Lee JM, Hong EG, Lee IK, Kim SW, Park JY, Hartig SM, Kang UJ, Moore DD, Koh EH, Lee KU. Ko MS, et al. Autophagy. 2021 May;17(5):1205-1221. doi: 10.1080/15548627.2020.1753002. Epub 2020 May 13. Autophagy. 2021. PMID: 32400277 Free PMC article.

8

CD226^hiCD8⁺ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.

Jin HS, Ko M, Choi DS, Kim JH, Lee DH, Kang SH, Kim I, Lee HJ, Choi EK, Kim KP, Yoo C, Park Y. Jin HS, et al. Among authors: ko m. Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7. Cancer Immunol Res. 2020. PMID: 32265229

9

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.

Jeon S, Ko M, Lee J, Choi I, Byun SY, Park S, Shum D, Kim S. Jeon S, et al. Among authors: ko m. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00819-20. doi: 10.1128/AAC.00819-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32366720 Free PMC article.

10

ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.

Vaisitti T, Arruga F, Vitale N, Lee TT, Ko M, Chadburn A, Braggio E, Di Napoli A, Iannello A, Allan JN, Miller LL, Lannutti BJ, Furman RR, Jessen KA, Deaglio S. Vaisitti T, et al. Among authors: ko m. Blood. 2021 Jun 17;137(24):3365-3377. doi: 10.1182/blood.2020008404. Blood. 2021. PMID: 33512452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results